IFF vs SXT: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: IFF is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. IFF and SXT share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined IFF and SXT exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

International Flavors & Fragrances makes the taste, scent and functional ingredients that go into other companies' products: flavor systems for beverages, snacks and dairy, fine and consumer fragrances, enzymes, cultures, probiotics and soy proteins. The company traces to 1833 and reached its current scale through the 2018 Frutarom acquisition and the February 2021 Reverse Morris Trust merger with DuPont's Nutrition & Biosciences division, a roughly $26 billion combination that made IFF one of the four global ingredient houses alongside Givaudan, dsm-firmenich and Symrise. As of the second quarter of 2026 it reports three continuing segments, Taste (~$688 million of quarterly sales), Health & Biosciences (~$601 million) and Scent (~$665 million), after moving the Food Ingredients and Soy Crush businesses into discontinued operations.

Full IFF guide

Sensient Technologies is a Milwaukee-based manufacturer of colors, flavors, and functional ingredients used in food and beverage, pharmaceutical, nutraceutical, and personal-care products. It runs three reporting segments: Color (natural and synthetic color systems), Flavors & Extracts (flavor systems, extracts, essential oils, and dehydrated agricultural ingredients like garlic and onion), and Asia Pacific (color and flavor distribution plus products like chili powder and paprika across the Pacific Rim and India). The company sells specialized, formulation-critical ingredients that are a small share of a customer's cost but hard to swap out, which supports pricing power and sticky relationships.

Full SXT guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• IFF drivers: The Food Ingredients sale and the capital return attached to it; Deleveraging from the DuPont merger is essentially complete.
• SXT drivers: Natural-color regulatory conversion; Capacity investment (Project Prism).

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The CVC transaction is not expected to close until the end of the second quarter of 2027 and remains subject to regulatory approvals, so both the $2.0 billion post-close buyback and the promised debt paydown are contingent rather than banked. For SXT, the stock trades at a premium multiple (a trailing P/E in the mid-30s, above its long-run median), so much of the natural-color optimism may already be reflected in the price and disappointment could compress the valuation.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick IFF if you believe its drivers more; SXT if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the IFF and SXT guides.

IFF. The two revenue figures are not a contradiction: trailing revenue of ~$10.8 billion covers the whole company, while 2026 guidance of ~$7.4 billion to ~$7.6 billion covers only the three segments IFF is keeping, since Food Ingredients and the Soy Crush businesses moved to discontinued operations in the second quarter. Trailing GAAP EPS of ~$1.08 puts the shares near 78 times earnings, a number distorted by amortization and disposal charges, which is why the forward multiple of roughly 25 times is the one most analysts quote. Enterprise value of about $26.6 billion against ~$2.06 billion of trailing credit adjusted EBITDA works out near 13 times, while Food Ingredients is being sold at roughly 8 times its own EBITDA.

SXT. Q1 2026 was strong, with revenue up about 11% to ~$436 million, gross margin expanding to ~35%, and diluted EPS rising to ~$1.04, prompting management to raise full-year guidance. The trailing P/E in the mid-30s sits above Sensient's roughly 29x ten-year median, reflecting optimism about the natural-color opportunity. The ~1.4% dividend yield reflects a long, steadily growing payout history rather than a high-yield profile.

Headline figures (approximate, August 2026): IFF shows revenue (ttm, all businesses) ~$10.8B, fy 2026 sales guidance (continuing operations) ~$7.4B to ~$7.6B, q2 2026 adjusted operating ebitda margin ~20.9%, adjusted eps ex-amortization (first half 2026) ~$1.74; SXT shows revenue (ttm) ~$1.7B, q1 2026 revenue ~$436M (up ~11%), net income (ttm) ~$150M, 2026 eps guidance (gaap) ~$3.70 to $3.90.

IFF and SXT are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined IFF and SXT exposure against your real portfolio. It is not an investment adviser.